Hoge Elizabeth has filed 8 insider transactions across 1 company since April 2024.
Most recent transaction: a option exercise of 22740 shares of Cartesian Therapeutics, Inc. ($RNAC) on April 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | M | Series A Non-Voting Convertible Preferred Stock | 22740 | $0.00 | 33,662.2240 | 26,003,606 | 40.32% | 0.09% |
| April 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | M | Common Stock | 758001 | $0.00 | 5,820,260.0000 | 26,003,606 | 14.97% | 2.92% |
| Oct. 11, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | M | Common Stock | 1518373 | $0.00 | 5,061,637.0000 | 23,896,525 | 42.85% | 6.35% |
| Oct. 11, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | M | Series A Non-Voting Convertible Preferred Stock | 45551 | $0.00 | 56,402.2540 | 23,896,525 | 44.68% | 0.19% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | C | Series A Non-Voting Convertible Preferred Stock | 87803 | $0.00 | 101,953.4440 | 5,515,836 | 46.27% | 1.59% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | C | Series A Non-Voting Convertible Preferred Stock | 14756 | $0.00 | 101,953.4440 | 5,515,836 | 12.64% | 0.27% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | C | Common Stock | 491853 | $0.00 | 3,543,264.0000 | 5,515,836 | 16.12% | 8.92% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Hoge Elizabeth | TenPercentOwner | C | Common Stock | 2926764 | $0.00 | 3,543,264.0000 | 5,515,836 | 474.74% | 53.06% |